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Objectives: This study aimed to evaluate a novel three-dimensional ultrasound (US) guidance system
for use in hepatic microwave ablation (MWA).
Methods: An in vitro assessment was performed in which users with different degrees of experience
were evaluated for accuracy in targeting phantom lesions embedded in agar using US alone, or US in
conjunction with the InVision™ System (IVS). An eight-patient pilot trial of the IVS was then performed in
the setting of open hepatic MWA, in which lesions would otherwise have been targeted with conventional
US.
Results: In vitro studies demonstrated that the IVS significantly improved targeting accuracy at all levels
of operator experience (novice, beginner and expert). In the human trial, a total of 31 tumours were
targeted and all lesions were hit in one pass, as assessed by independent US image observations. There
were no adverse operative events; however, there was minor line-of-sight interference with the infra-red
tracking mechanism when some lesions high on the dome of the liver were targeted.
Conclusions: The IVS significantly increased the accuracy of complex targeting procedures of phantom
lesions and enhanced targeting in an eight-patient clinical pilot study. During the accrual phase of this
pilot study, the development of improved non-optical tracking hardware obviated the requirement to
maintain a direct line of sight. The trial was then halted prematurely in order to focus on the application
of the IVS utilizing this non-optical modality.
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Introduction
Ultrasound (US) is the current modality of choice for intraopera-
tive imaging of the liver and liver tumours, providing surgeons
with real-time anatomic images from a dynamic, mobile surgical
field.1,2 Intraoperative US is an essential tool for surgeons during
laparoscopic and open hepatic resections, as well as in the target-
ing of liver lesions for biopsy or ablation.3–5 Despite the versatility
and real-time information that US provides, the images are
provided in a two-dimensional (2-D) format, which requires the
surgeon to mentally reconstruct the spatial relations of the target
lesion and hepatic anatomy in three dimensions (3-D). In the
setting of lesion targeting for tumour ablation, the position of the
lesion in relation to both the intra- and extrahepatic anatomy
determines the trajectory at which the ablation antenna must be
introduced.When this trajectory or angle is ‘out of plane’ with the
2-D US image, the ablation antenna will not be seen until it
crosses the US plane and even then it will only appear as a bright
dot on the US image. Conversely, it is much easier to visualize the
ablation antenna or biopsy needle when performing a task ‘in
plane’. The process of mentally reconstructing a 3-D image of a
liver lesion and locating the ablation antenna within the 2-D US
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image represents an extremely difficult and complex task. Even
experienced liver surgeons may have difficulty in interpreting US
images of the liver and it is not unheard of for surgeons to invite
their radiologist colleagues to the operating theatre for an intra-
operative US consult.6 Imprecise tumour targeting can increase
the probability of inadvertent injury to adjacent structures and
incomplete tumour ablation. For these reasons, difficulties asso-
ciated with liver tumour targeting during ablation contributed to
the significantly high local recurrence rates reported in the early
ablation literature.7
An ideal targeting system would combine real-time imaging
and versatile positioning of US in a 3-D representation of the
targeting equipment (either a biopsy needle or ablation antenna)
and the relevant hepatic anatomy, thus minimizing the require-
ment for mental reconstruction. Such targeting systems have
been developed with the aim of improving needle biopsy accu-
racy for superficially accessible lesions in the breast and
prostate.8–10 With specific reference to liver tumour ablation, it
has been shown that providing the operator with a 3-D US
image improves the accuracy of ablation instrument place-
ment.11,12 These studies were performed with US devices capable
of reconstructing a 3-D image after the operator has scanned
over the target lesion with a 2-D US handpiece. This 3-D tech-
nology is an important aid in pre-ablation planning and in con-
firming the position of the needle after placement, but it is not
capable of real-time 3-D reconstruction during actual needle
positioning.
The aim of this study was to assess the clinical applicability
of a novel US targeting system capable of providing a real-
time 3-D reconstruction of the target lesion and ablation
instrument.
The ablation modality of choice in clinical practice at this insti-
tution is microwave ablation (MWA), which transmits electro-
magnetic energy at a high frequency (from 300 MHz to 10 GHz)
into the surrounding tissue without requiring the point-to-point
current necessary in radiofrequency ablation (RFA).13 Within the
microwave field, the heat generates results in a homogeneous and
uniform zone of coagulative necrosis that is not susceptible to the
heat sink effect seen in RFA when performed near blood vessels.14
This results in a more predictable and consistent ablation zone,
which is associated with lower recurrence rates when utilized for
hepatic tumour ablation.15
Materials and methods
Institutional assurances
Approval was obtained from the Carolinas Medical Center Insti-
tutional Review Board for a human pilot study of 10 patients
utilizing the InVision™ System (IVS) for guidance in open MWA
of liver tumours that would otherwise be targeted with conven-
tional 2-D US. The decision to use MWA as opposed to other
modalities was not altered by inclusion in this study. Informed
consent was obtained from all patients.
Overview of the targeting system
The InVision™ System (InnerOptic Technology, Inc., Hillsbor-
ough, NC, USA) is a computer-based image guidance system. The
IVS is linked to a commercially available infra-red tracking system
(Northern Digital, Inc., Waterloo, ON, Canada) which monitors
the position of specialized reflective ‘tracking mounts’ that are
attached to the US handpiece and ablation antenna (Fig. 1). Dual
infra-red cameras, attached to a boom and separated by a fixed
distance, observe the tracking mounts as they are moved within
the operative field. From these two stereo video streams, the posi-
tion and orientation of the tracking mounts is triangulated con-
tinuously. In this aspect, the system is not unlike any other infra-
red motion detection system.
The novel aspect of the IVS refers to how the real-time position
and orientation of the tracking mounts are acquired from the
infra-red cameras and translated into a virtual representation of
(A)
(B)
Figure 1 (A) Microwave antenna and ultrasound handpiece fitted
with specialized retro-reflectors used with the InVision™ System
(IVS). Agar blocks containing phantom tumours were made for
ex vivo instrument evaluation. (B) Operative performing ex vivo
phantom tumour location and antenna placement using the IVS
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the ablation antenna and US image in three dimensions on a video
monitor.
Before the system is used, a computer-generated virtual rep-
resentation of the ablation antenna, based on its exact size and
shape, is created and stored in the computer. Then, during the
targeting procedure, the IVS software acquires information from
the infra-red cameras as they follow the position and orientation
of the tracking mount on the real antenna. The software
then combines this positional information with the stored
virtual representation of the antenna. This combination of
real-time positional information and virtual antenna image is
then displayed on a 3-D LCD monitor (Miracube/Pavonine
Korea, Inc., Incheon, South Korea). Thus, the virtual antenna
image on the monitor screen moves in three dimensions
and in real time as the operator moves the actual antenna in the
surgical field.
In detail, the actual flat 2-D US image is displayed on the 3-D
monitor so that the operator is able to observe the target lesion
and surrounding anatomy in real time, as with any conventional
2-D US imaging system. At the same time, however, the infra-red
cameras track the position and orientation of the tracking mount
on the US handpiece and feed this information to the IVS software
in real time. The IVS software then links this positional informa-
tion to the 2-D US image. Thus, as the operator rotates or moves
the US handpiece, the flat 2-D US image on the monitor rotates
and moves in three dimensions.
The operator then puts on passive stereo glasses (similar to
those used in 3-D movie theatres). Now the operator sees, on a
3-D monitor, a flat 2-D US image and a virtual representation of
the ablation antenna moving in exact relation to one another and
exactly mimicking the orientation and movement of the real US
handpiece and ablation antenna in the operative field (Fig. 2).
(A) (B)
(C) (D)
Figure 2 Representative screen shots taken from the monitor demonstrating in 3-D the 2-D ultrasound (US) image, virtual ablation antenna
and predicted antenna tract. (A, B) Representative screen shots of tumour targeting. (C) Representative screen shot of a phantom tumour
in an experimental pig model showing the 3-D representation of the predicted ablation zone. (D) Photograph of monitor displaying imaging
performed during microwave ablation (MWA) of a hepatic tumour in the human MWA study, showing 3-D representation of the predicted
ablation zone
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When used clinically for ablation, the IVS software also provides a
3-D representation of the predicted ablation zone in order to
facilitate visual confirmation that the intended target is within
range for complete ablation (Fig. 2C, D).
The computational core of the system consists of proprietary
software developed by InnerOptic Technology, Inc., which is run
on a standard, commercially available desktop computer (Dell
Optiplex 755; Dell, Inc., Hillsboro, OR, USA) using a high-
performance graphics card (GeForce 9400GT; Nvidia Corp., Santa
Clara, CA, USA).
Preclinical experimental design
To evaluate the targeting system for use in MWA, a phantom
tumour model was developed to compare the accuracy of antenna
placement between conventional 2-D US and the novel guidance
system. Phantom tumours were created by embedding 6–8-mm
fragments of egg white approximately 3 cm deep into an opaque
agar gel block (Fig. 1A). A B-K Pro Focus 2202 US device with a
surgical T-probe (B-K Medical A/S, Herlev, Denmark) was used
alone for conventional US or in conjunction with the IVS (Fig. 1).
A standard 13-gauge microwave antenna (Valleylab, Inc., Boulder,
CO, USA) was used for all targeting attempts. Three operators
with varying degrees of experience in US were compared. The
operators included a fourth-year medical student with no US or
targeting experience (novice), a research fellow who had com-
pleted general surgery training and had some US targeting expe-
rience (intermediate), and a hepatopancreatobiliary (HPB)
attending doctor with extensive US guided targeting experience
(expert).
The ablation antenna was placed using standard procedures for
liver tumour MWA. The phantom was first located with the US
handpiece and the antenna introduced at one of three designated
angles (0°, 45°, 90°) relative to the US plane (0° corresponded to
‘in plane’ and 90° corresponded to ‘out of plane’). For each
attempt, the angle was chosen randomly. Each user made 10
needle placement attempts at each of the three angles, with and
without the guidance system. Use of the guidance system vs. con-
ventional US was randomized across placement attempts. Users
were not allowed to alter the course of the needle antenna once the
agar block had been punctured. Data on the accuracy of antenna
placement were collected by US confirmation in two orthogonal
planes with the antenna in the final position selected by the opera-
tor. For the attempt to qualify as a ‘hit’, the tip was required to
penetrate the target; however, if the needle tip passed through the
target entirely, the attempt was recorded as a ‘miss’.
Human pilot trial design
A human pilot study with eight patients was performed utilizing
the IVS for open MWA of liver tumours that would otherwise be
targeted with conventional 2-D US. Following the administration
of general anaesthesia, the abdomen was prepped and draped in
the usual fashion and the infra-red tracking system and monitor
of the guidance system were positioned at the head of the patient
(Fig. 3A). The reflective tracking mounts were fitted to a B-K Pro
Focus 2202 US device with a surgical T-probe and one of two
different MWA antennae in a sterile fashion using conventional
US sleeves (Fig. 3B). Both commercially available MWA systems
were employed: one is a 915-MHz system (Valleylab, Inc.) and the
other is a 2.45-GHz system (Acculis Ltd/Microsulis Medical Ltd,
Denmead,UK). In each patient, the surgeon (JBM,DAI) chose the
particular system and antenna based on the characteristics of each
patient’s tumours. The openMWA proceeded in the usual fashion
through an upper midline or subcostal incision and retractors
were placed as needed. Ultrasound images from each targeting
attempt were recorded for independent review by a radiologist
(B)
(A)
Figure 3 (A) Operating room positioning of the infra-red tracking
system and monitors. (B) Reflective tracking mounts fitted to a B-K
ProFocus 2202 ultrasound (US) device and a microwave ablation
(MWA) probe wrapped with US sleeves as used to perform an open
MWA of a human hepatic lesion
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experienced in percutaneous tumour ablation. The number of
tumours targeted, tumour size, MWA system used, number of
passes required to hit the lesion, percentage of lesions hit and
adverse events were recorded. Stored US images were evaluated by
an independent radiologist to confirm the accuracy of targeting.
Statistical analysis
Results are expressed as simple counts. Groups were compared
using chi-squared analysis. A P-value of <0.05 was considered
statistically significant. jmp Version 8 (SAS Institute, Inc., Cary,
NC, USA) was used for statistical analysis.
Results
Preclinical data
Data comparing operator status and the accuracy of needle place-
ment using either 2-D US or the IVS are shown in Table 1. When
all operators were assessed together, accuracy was found to
improve significantly at all angles with use of the IVS (Table 2). Of
further note, the novice using the IVS achieved a higher rate of
accuracy than the expert using conventional US (P < 0.05)
(Table 1).
Human pilot study
Eight patients were enrolled in the study, presenting a total of 31
tumours to be targeted. Median tumour diameter was 1.5 cm
(range: 0.4–8.0 cm). All 31 lesions were hit in one pass and accu-
rate antenna placement was confirmed by an experienced inde-
pendent radiologist who reviewed all US images for each patient.
There were no adverse events in the operative or postoperative
settings. Although the IVS software and visual display technology
greatly simplified the targeting process, it was noted that the appli-
cation of the infra-red tracking system in the setting of open
hepatic tumour ablation resulted in transient line-of-sight issues
in three of the eight patients, whereby the abdominal wall retrac-
tors or abdominal wall obscured the path from the infra-red
camera to the tracking mounts attached to the instruments, thus
momentarily interfering with transmission to the IVS software.
This disruption had no detrimental effect on the accuracy of
lesion targeting, but it made hand positioning and the actual task
of ablation difficult at times. The IVS software and visual display
technology were subsequently adapted to a non-optical tracking
system to eliminate these line-of-sight difficulties during open
procedures and to expand the role of this targeting technology to
the laparoscopic setting. The decision was then made to halt
accrual into this open MWA trial and to continue further clinical
investigation with the IVS utilizing the non-optical tracking
modality in a laparoscopic setting.
Discussion
Ultrasound guidance is indispensable in the intraoperative target-
ing of hepatic lesions for biopsy or ablation, and accuracy in this
Table 1 Laboratory targeting data using conventional 2-D ultrasound (US) (non-guided) or the InVision™ System
Hits at 0
degrees, n
Hits at 45
degrees, n
Hits at 90
degrees, n
Total hits
(n = 30 attempts)
Novice
Non-guided 3 3 0 6
InVision™ System 9 10 6 25
Intermediate
Non-guided 4 2 2 8
InVision™ System 8 9 7 24
Expert
Non-guided 5 7 6 18
InVision™ System 10 10 10 30
n = 10 attempts at antenna placement per group (non-guided vs. InVision™ System) per angle (0°, 45°, 90°), where 0° is parallel to or ‘in plane’ with
the US image and 90° is orthogonal to or ‘out of plane’ with the US image
Table 2 Combined data from all users comparing conventional 2-D ultrasound (US) with the InVision™ System at each angle in respect to
the 2-D US plane
Non-guided
(n = 30 attempts)
InVision™
(n = 30 attempts)
P-value
Hits at 0°, n 12 27 <0.001
Hits at 45°, n 12 29 <0.001
Hits at 90°, n 8 23 <0.001
n = 30 attempts at antenna placement per group (non-guided vs. InVision™ System) per angle (0°, 45°, 90°), where 0° is parallel to or ‘in plane’ with
the US image and 90° is orthogonal to or ‘out of plane’ with the US image
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targeting is paramount to avoid injury to adjacent tissue and to
deliver adequate thermal energy to the target lesion.5–7 Other
forms of imaging, such as computed tomography or magnetic
resonance imaging, can provide detailed 3-D models for preop-
erative planning, yet these modalities lack the ability to give
second-to-second real-time feedback to the operator as the dia-
phragm and liver move with respiration. Only US offers this
ability; however, US also has disadvantages that must be
addressed. Ultrasound targeting of hepatic lesions is hindered by
the complex vascular and biliary anatomy of the liver, as well as by
the physical constraints of the abdominal cavity. As a result, the
targeted lesion must often be approached ‘out of plane’ to the 2-D
US image. This imposes a task of increased mental complexity as
the operating surgeon must then ‘recreate’ a 3-D image of the
lesion from the information available. With these constraints in
mind, an image guidance system that is able to decrease themental
and proprioceptive challenges of hepatic tumour targeting while
maintaining the versatility and real-time feedback afforded by US
has been developed.
These preclinical data clearly demonstrate that this novel 3-D
US guidance system allows even those operators with little or no
experience in using US or targeting lesions to accurately target
phantom lesions that they would otherwise have missed. In addi-
tion, the novice or intermediate operator using this targeting
system was more accurate than the experienced HPB attending
surgeon using conventional 2-D US. However, the novel targeting
system also allowed the expert operator to improve antenna place-
ment significantly. By visually representing the exact relationship
between instruments and operator, the system significantly
reduces the cognitive load borne by the surgeon and increases the
accuracy of targeting.
The results of this human pilot study in applying this guidance
system to open MWA revealed that the targeting accuracy seen in
the laboratory can be attained in the complex environment of
open liver surgery with little technical difficulty. The system was
easy to set up and manoeuvre in the operating room and targeting
was greatly simplified by the IVS software, even for HPB surgeons
experienced in hepatic lesion targeting and ablation. The only
drawback of the system was the aforementioned line-of-sight
issue that was a product of the infra-red tracking system used.
This problem arose when operators targeted lesions high on the
dome of the liver for which the required angle of approach, in
conjunction with the abdominal wall and retractors, obscured the
position of the tracking mounts, thus transiently disabling the
infra-red tracking system.
It was promptly recognized that any obscuration of the line of
sight would be an occasional minor inconvenience in open abla-
tion, but would represent amajor impediment to the development
of a laparoscopic version of this technology. As the facility to use
this system in minimally invasive procedures would greatly
broaden its applicability, the distinct advantages of the IVS soft-
ware and image display technology were then coupled with a
non-optical tracking modality for use in open or laparoscopic
procedures. As a single prototype IVS unit had been used in this
investigation and the advantages and limitations conferred by the
infra-red tracking modality were well delineated after trialling in
eight patients, we decided to continue clinical investigation with
the IVS and the non-optical tracking modality in a laparoscopic
setting.
In summary, this study demonstrates that the incorporation of
a real-time 3-D US guidance system significantly increases the
accuracy with which complex targeting procedures can be per-
formed. The IVS software and image display technology greatly
reduce the mental complexity of lesion targeting during open liver
ablation procedures. The only obstacle encountered involved the
infra-red tracking system; this will need to be addressed using a
non-optical tracking modality that does not depend on the pres-
ence of a clear path from the sensor to the instruments, thus
allowing this highly applicable technology to move forward to a
minimally invasive approach. Current investigations revolve
around the incorporation of low-frequency magnetic positioning
into the InVision™ System.
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